Consistently, a protein preload significantly decreases postprandial glycemia and increases plasma insulin levels in patients with type 2 diabetes, which is partially attributed to the elevation of GLP-1 and GIP levels [201,202]. This evidence concerns the gene INS and type 2 diabetes mellitus.